Not applicableUnknownNCT05491057What this trial is testingTreatment Patterns of Neratinib in HER2+ EBC in ChinaWho this might be right forBreast Cancer Pierre Fabre Medicament 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06733233What this trial is testingA Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast CancerWho this might be right forBreast Cancer, Estrogen Receptor-PositiveHER2 Low Breast Cancer Guangzhou Women and Children's Medical Center 23
Very early researchStudy completedNCT00949247What this trial is testingDocetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow MicrometastasesWho this might be right forBreast Cancer Case Comprehensive Cancer Center 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04514419What this trial is testingTreatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + DocetaxelWho this might be right forBreast Cancer BioRay Pharmaceutical Co., Ltd. 408
Not applicableStudy completedNCT01928186What this trial is testingFLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerWho this might be right forEstrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more University of Washington 28
Large-scale testing (Phase 3)Temporarily pausedNCT06671912What this trial is testingTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialWho this might be right forAnatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+4 more Alliance for Clinical Trials in Oncology 1,556
Testing effectiveness (Phase 2)Active Not RecruitingNCT05252988What this trial is testingThree Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant NeratinibWho this might be right forEarly-stage Breast CancerHER2 Positive Breast CancerHormone Receptor Positive Spanish Breast Cancer Research Group 177
Testing effectiveness (Phase 2)Looking for participantsNCT04985266What this trial is testingA Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast CancerWho this might be right forER+ Breast CancerHER2-negative Breast Cancer Royal Marsden NHS Foundation Trust 1,100
Not applicableLooking for participantsNCT07484087What this trial is testingAblation Compare With Surgery for Early Breast CancerWho this might be right forBreast CancerEarly StageHormone Receptor Positive+1 more Peking University People's Hospital 264
Testing effectiveness (Phase 2)UnknownNCT04659499What this trial is testingNab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast CancerWho this might be right forEarly Breast Cancer Peking Union Medical College Hospital 261
Testing effectiveness (Phase 2)Looking for participantsNCT05891561What this trial is testingShort-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast CancerWho this might be right forBreast Cancer Shanghai Jiao Tong University School of Medicine 120
Large-scale testing (Phase 3)Study completedNCT00553358What this trial is testingNeo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) StudyWho this might be right forNeoplasms, Breast Novartis Pharmaceuticals 455
Testing effectiveness (Phase 2)UnknownNCT06470347What this trial is testingA Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab TherapyWho this might be right forHER-2 Positive Advanced Breast Cancer Zunyi Medical College 67
Large-scale testing (Phase 3)Study completedNCT05415215What this trial is testingEvaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast CancerWho this might be right forEarly Breast CancerLocally Advanced Breast CancerInflammatory Breast Cancer Hoffmann-La Roche 346
Not applicableLooking for participantsNCT06930521What this trial is testingJUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First YearWho this might be right forCardiovascular HealthBreast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)+4 more Women's College Hospital 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07317778What this trial is testingChemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast CancerWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3)HR Positive/HER2 Low Breast Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 249
Testing effectiveness (Phase 2)Study completedNCT00493649What this trial is testingAdj TC + Herceptin Early Stage Breast CancerWho this might be right forBreast Cancer US Oncology Research 493
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07795424What this trial is testingCulmerciclib Combined With Letrozole and Dual HER2 Blockade as Neoadjuvant Therapy for HR+/HER2+ Breast CancerWho this might be right forBreast CancerHR Positive, HER2 Positive Breast Cancer Shengjing Hospital 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07416253What this trial is testingTrastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast CancerWho this might be right forBreast Cancer Henan Cancer Hospital 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07136974What this trial is testingEfficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.Who this might be right forBreast CancerHER2 + Breast Cancer Henan Cancer Hospital 280